DSR-141562
DSR-141562, also known as LMN75224 is a phosphodiesterase 1 inhibitors useful for treatment of neurological and psychiatric disorder. DSR-141562 exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia. DSR-141562 has preferential selectivity for predominantly brain-expressed PDE1B over other PDE1 family members, and high selectivity for the PDE1 family over other PDE families and 65 other tested biologic targets.
Supplier | Ace Therapeutics |
---|---|
Product # | SMD1510 |
CAS # | 2007975-22-4 |
Pricing | Customizable size, Inquiry |
Synonym | DSR-141562; DSR-141562; DSR141562; DSR141562; ; LMN75224; LMN-75224; LMN 75224; |
Product Category | Lab-use Small Molecule Drugs |
Chemical Formula | C19H25F3N4O3 |
Exact Mass | 414.1879 |
Molecular Weight | 414.4292 |
Elemental Analysis | C, 55.07; H, 6.08; F, 13.75; N, 13.52; O, 11.58 |
IUPAC/Chemical Name | 3-Methyl-7-(tetrahydro-2H-pyran-4-yl)-2-[[trans-4-(trifluoromethyl)cyclohexyl]methoxy]imidazo[5,1-f][1,2,4]triazin-4(3H)-one |
InChi Key | LNELWUPBSLZUIQ-MQMHXKEQSA-N |
InChi Code | InChI=1S/C19H25F3N4O3/c1-25-17(27)15-10-23-16(13-6-8-28-9-7-13)26(15)24-18(25)29-11-12-2-4-14(5-3-12)19(20,21)22/h10,12-14H,2-9,11H2,1H3/t12-,14- |
SMILES Code | O=C1N(C)C(OC[C@H]2CC[C@H](C(F)(F)F)CC2)=NN3C1=CN=C3C4CCOCC4 |
Appearance | Solid powder |
Purity | >98% (or refer to the Certificate of Analysis) |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Shelf Life | >3 years if stored properly |
Drug Formulation | This drug may be formulated in DMSO |
Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
HS Tariff Code | 2934.99.9001 |
Availability | 2 Weeks |